Dr. Maha Katabi
CIK 1720685 · View on SEC EDGAR ↗
Insider
Activist
First SEC filing: June 29, 2021 · Latest: Feb. 25, 2025
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 12 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
12 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 25, 2024 | VERA | S | 340,000 | $40.50 | $13,770,000 | 2,793,987 Indirect | -10.85% | Disposed | -22.0% (price as of 2026-08-20) |
| March 22, 2024 | VERA | S | 413,450 | $40.51 | $16,748,860 | 3,133,987 Indirect | -11.65% | Disposed | -22.1% (price as of 2026-08-20) |
| March 21, 2024 | VERA | S | 13,718 | $46.18 | $633,497 | 3,547,437 Indirect | -0.39% | Disposed | -31.6% (price as of 2026-08-20) |
| March 21, 2024 | VERA | S | 12,617 | $45.52 | $574,326 | 3,561,155 Indirect | -0.35% | Disposed | -30.6% (price as of 2026-08-20) |
| March 21, 2024 | VERA | S | 21,918 | $44.00 | $964,392 | 3,573,772 Indirect | -0.61% | Disposed | -28.2% (price as of 2026-08-20) |
| March 21, 2024 | VERA | S | 32,756 | $43.00 | $1,408,508 | 3,595,690 Indirect | -0.90% | Disposed | -26.6% (price as of 2026-08-20) |
| Jan. 30, 2024 | VERA | P | 161,290 | $31.00 | $4,999,990 | 3,628,446 Indirect | +4.65% | Acquired | 1.8% (price as of 2026-08-20) |
| July 2, 2021 | JBIO | P | 357,142 | $14.00 | $4,999,988 | 3,758,686 Indirect | +10.50% | Acquired | -95.6% (price as of 2026-08-20) |
| May 18, 2021 | VERA | P | 727,272 | $11.00 | $7,999,992 | 2,914,776 Indirect | +33.25% | Acquired | 187.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 10, 2023 | VERA | Stock Option (right to buy) | Class A Common Stock (20,000) | $7.70 | May 9, 2033 | 20,000 | Acquired |
| Jan. 3, 2023 | JBIO | Stock Option (Right to Buy) | Common Stock (2,627) | $27.03 | Jan. 2, 2033 | 2,627 | Acquired |
| May 24, 2022 | VERA | Stock Option (right to buy) | Class A Common Stock (9,925) | $16.14 | May 23, 2032 | 9,925 | Acquired |
| July 2, 2021 | JBIO | Series A Preferred Stock | Common Stock (3,401,544) | — | — | 10,565,238 | Disposed |
| July 1, 2021 | JBIO | Stock Option (Right to Buy) | Common Stock (2,467) | $19.41 | June 30, 2031 | 2,467 | Acquired |
| June 29, 2021 | JBIO | Stock Option (Right to Buy) | Common Stock (25,000) | $14.00 | June 28, 2031 | 25,000 | Acquired |
| June 4, 2021 | JBIO | Series A Preferred Stock | Common Stock (2,602,112) | — | — | 8,082,190 | Acquired |
| May 18, 2021 | VERA | Series C Preferred Stock | Class A Common Stock (2,187,504) | — | — | 2,187,504 | Disposed |
| May 13, 2021 | VERA | Stock Option (right to buy) | Class A Common Stock (9,925) | $11.00 | May 12, 2031 | 9,925 | Acquired |
| Feb. 1, 2021 | JBIO | Series A Preferred Stock | Common Stock (374,825) | — | — | 1,164,213 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.